The Korea Food and Drug Administration announced that licenses for new products totaled 53 in the period of November 23-27.
Of the licenses, prescription drugs accounted for 19, OTCs for 10, raw materials for 6 and oriental medicine for 18.
The drug agency okayed Ursa tablets as an additional dosage form in addition to a capsule form.
The KFDA also said Lilly’s Strattera 80 mg (atomoxe...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.